Bayesian Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-83,500
| Closed | -$433K | – | 1059 |
|
|
2024
Q3 | $433K | Buy |
+83,500
| New | +$433K | 0.05% | 407 |
|
|
2022
Q3 | – | Sell |
-18,700
| Closed | -$258K | – | 1072 |
|
|
2022
Q2 | $258K | Buy |
18,700
+3,900
| +26% | +$53.8K | 0.05% | 532 |
|
|
2022
Q1 | $289K | Buy |
+14,800
| New | +$289K | 0.04% | 537 |
|